MichaelGFradleyMD
Cardiology • Philadelphia, PACardiac Electrophysiology
Medical Director, Penn Cardio-Oncology, Associate Professor of Clinical Medicine
Dr. Fradley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd -- PCAM
3rd Floor
Philadelphia, PA 19104Phone+1 215-662-7700Fax+1 215-349-5533
Education & Training
Massachusetts General HospitalFellowship, Clinical Cardiac Electrophysiology, 2011 - 2012- Massachusetts General HospitalFellowship, Cardiovascular Disease, 2008 - 2011
Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008- Johns Hopkins University School of MedicineClass of 2005
Certifications & Licensure
PA State Medical License 2020 - 2026
FL State Medical License 2013 - 2021
MA State Medical License 2008 - 2014
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy Start of enrollment: 2014 Nov 01
- Long Term Arrhythmia Risk and Cardiovascular Events in Hematopoietic Stem Cell Transplant Start of enrollment: 2021 Apr 21
Publications & Presentations
PubMed
- Experiences of Lesbian, Gay, Bisexual, Transgender, and Queer Cardiology Physicians and Fellows in Training.Stephen C Cook, Geoffrey D Barnes, Kathryn Berlacher, Quinn Capers 4th, Michael G Fradley
JACC. Advances. 2025-02-01 - CARDIAC-STAR: prevalence of cardiovascular comorbidities in patients with HR + /HER2 - metastatic breast cancer.Susan Dent, Avirup Guha, Heather Moore, Doris Makari, Rachael McCaleb
Cardio-Oncology. 2025-01-27 - BTKi-induced cardiovascular toxicity in CLL: Risk mitigation and management strategies.Sofija Kozarac, Vojin Vukovic, Michael Fradley, Darko Antic
Blood Reviews. 2025-01-24
Press Mentions
Lung Cancer Drug Osimertinib Tied to Cardiac Events, Even in Low-Risk PatientsDecember 12th, 2024- Heart Failure Risk Lingers Long After Chemotherapy, Regardless of DoseFebruary 3rd, 2023
- Cardio-Oncology Topics from AHA 2020August 17th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
